Simone Biles Partnered to Raise Skin Condition Awareness

The athlete is sharing her experience with managed care to encourage others to discuss treatment options with their doctors.

Updated on Sept. 29, 2026 in Beauty

Bold vector editorial illustration of a skincare jar on linen, representing healthcare management and patient-centered care. — Simone Biles is partnering with Arcutis Biotherapeutics for the 'Skin to Believe In' campaign to encourage patients to seek professional medical care for chronic inflammatory skin conditions. AI Illustration. Upload story photo >

Live Poll

Do you trust celebrity-led awareness campaigns for prescription medications?

Simone Biles has joined with Arcutis Biotherapeutics for the Skin to Believe In campaign, which aims to reduce the stigma surrounding chronic inflammatory skin conditions. The initiative encourages the 36 million Americans living with these issues to seek professional care.

Why it matters

By sharing her personal journey, Biles hopes to help patients feel empowered to have conversations with healthcare providers about managing conditions like seborrheic dermatitis and eczema. The campaign highlights that consistent medical care is a key step in finding effective management strategies.

Clinical trials for ZORYVE involved 458 participants for the foam and over 1,300 for the cream. In these pivotal studies, 77% of foam users and 31% of cream users achieved clear skin, though the precise long-term effects of this PDE4 inhibitor for all patient demographics remain under study.

The players

Simone Biles

An elite gymnast who uses medical treatments to manage seborrheic dermatitis and eczema.

Arcutis Biotherapeutics

A pharmaceutical company based in Westlake Village, California, focused on developing therapies for inflammatory skin conditions.

The details

ZORYVE is a steroid-free PDE4 inhibitor applied topically once daily. By inhibiting the phosphodiesterase-4 enzyme, the treatment reduces the inflammation that drives chronic skin symptoms. Patients are encouraged to work with their providers to determine if this approach aligns with their specific dermatological needs.

2024: ZORYVE cream received Glamour's Beauty and Wellness Award.
June 2025: The American Academy of Dermatology issued treatment recommendations for ZORYVE.
September 29, 2026: Arcutis announced its partnership with Simone Biles.

Health Landscape

This campaign aligns with the clinical guidance established by the American Academy of Dermatology, which issued updated recommendations for ZORYVE in 2025. It reflects a broader shift toward integrating targeted, steroid-free PDE4 inhibitors into the standard of care for chronic skin conditions.

If you live with chronic skin issues, track your symptoms to discuss potential long-term, steroid-free treatment options with your doctor. Always consult with a physician to determine which therapy is appropriate for your specific health needs and skin type.

The takeaway

Chronic inflammatory skin conditions often require consistent medical management rather than temporary fixes. If you are struggling with persistent symptoms, bring a list of your current triggers and prior treatments to your next primary care visit.